Savior Lifetec Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
Savior Lifetec has been growing earnings at an average annual rate of 8.3%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been declining at an average rate of 5.9% per year. Savior Lifetec's return on equity is 3.4%, and it has net margins of 9.9%.
Anahtar bilgiler
8.3%
Kazanç büyüme oranı
9.6%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 18.5% |
| Gelir büyüme oranı | -5.9% |
| Özkaynak getirisi | 3.4% |
| Net Marj | 9.9% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Is Savior Lifetec (GTSM:4167) Using Too Much Debt?
Mar 29
Update: Savior Lifetec (GTSM:4167) Stock Gained 35% In The Last Five Years
Feb 22Savior Lifetec Corporation (GTSM:4167) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Jan 25Should You Use Savior Lifetec's (GTSM:4167) Statutory Earnings To Analyse It?
Dec 29Savior Lifetec (GTSM:4167) Seems To Use Debt Quite Sensibly
Dec 03
Gelir ve Gider Dağılımı
Savior Lifetec nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 1,213 | 121 | 131 | 91 |
| 31 Mar 24 | 1,088 | 104 | 123 | 100 |
| 31 Dec 23 | 1,050 | 30 | 112 | 111 |
| 30 Sep 23 | 986 | -55 | 111 | 110 |
| 30 Jun 23 | 1,047 | 94 | 108 | 114 |
| 31 Mar 23 | 1,180 | 88 | 104 | 116 |
| 31 Dec 22 | 1,266 | 36 | 106 | 119 |
| 30 Sep 22 | 1,347 | 48 | 97 | 131 |
| 30 Jun 22 | 1,378 | -142 | 98 | 152 |
| 31 Mar 22 | 1,545 | -124 | 106 | 165 |
| 31 Dec 21 | 1,744 | 10 | 111 | 167 |
| 30 Sep 21 | 1,976 | 131 | 129 | 179 |
| 30 Jun 21 | 2,026 | 233 | 130 | 170 |
| 31 Mar 21 | 1,904 | 240 | 124 | 174 |
| 31 Dec 20 | 1,827 | 251 | 149 | 179 |
| 30 Sep 20 | 1,636 | 201 | 135 | 180 |
| 30 Jun 20 | 1,548 | 158 | 136 | 191 |
| 31 Mar 20 | 1,450 | 100 | 145 | 189 |
| 31 Dec 19 | 1,319 | -5 | 108 | 188 |
| 30 Sep 19 | 1,194 | -159 | 131 | 186 |
| 30 Jun 19 | 1,113 | -257 | 133 | 158 |
| 31 Mar 19 | 1,122 | -275 | 130 | 148 |
| 31 Dec 18 | 1,105 | -360 | 136 | 143 |
| 30 Sep 18 | 1,173 | -300 | 123 | 142 |
| 30 Jun 18 | 1,302 | -187 | 128 | 171 |
| 31 Mar 18 | 1,432 | -89 | 124 | 195 |
| 31 Dec 17 | 1,618 | 22 | 120 | 216 |
| 30 Sep 17 | 1,781 | 95 | 127 | 229 |
| 30 Jun 17 | 1,801 | 30 | 119 | 236 |
| 31 Mar 17 | 1,704 | -77 | 123 | 237 |
| 31 Dec 16 | 1,532 | -208 | 127 | 243 |
| 30 Sep 16 | 1,303 | -389 | 130 | 247 |
| 30 Jun 16 | 1,185 | -457 | 128 | 256 |
| 31 Mar 16 | 1,127 | -494 | 125 | 254 |
| 31 Dec 15 | 1,121 | -494 | 125 | 256 |
| 30 Sep 15 | 1,195 | -424 | 109 | 257 |
| 30 Jun 15 | 1,119 | -443 | 110 | 253 |
| 31 Mar 15 | 1,081 | -401 | 105 | 257 |
| 31 Dec 14 | 1,019 | -356 | 100 | 257 |
| 30 Sep 14 | 933 | -343 | 93 | 264 |
| 30 Jun 14 | 961 | -245 | 87 | 255 |
| 31 Mar 14 | 968 | -245 | 86 | 232 |
| 31 Dec 13 | 1,001 | -229 | 87 | 208 |
Kaliteli Kazançlar: 4167 has high quality earnings.
Büyüyen Kar Marjı: 4167's current net profit margins (9.9%) are higher than last year (9%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 4167 has become profitable over the past 5 years, growing earnings by 8.3% per year.
Büyüme Hızlandırma: 4167's earnings growth over the past year (27.9%) exceeds its 5-year average (8.3% per year).
Kazançlar vs. Sektör: 4167 earnings growth over the past year (27.9%) exceeded the Pharmaceuticals industry -0.6%.
Özkaynak Getirisi
Yüksek ROE: 4167's Return on Equity (3.4%) is considered low.